Navigation Links
Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call

DAYTON, Ohio, June 12 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that it will release its third quarter fiscal 2008 financial results for the period ended May 31, 2008, before the NYSE opens on Monday, June 30, 2008. A live webcast of the conference call is scheduled for June 30 at 11:00 a.m., EDT with Peter C. Wallace, President and Chief Executive Officer, and Christopher M. Hix, Vice President and Chief Financial Officer. They will discuss the Company's performance and respond to questions from the financial community.

Robbins & Myers invites interested investors to listen to the webcast, which will be broadcast live on its website . A webcast replay also will be available at the website and a telephonic replay will be available beginning 1:00 p.m., EDT on June 30, 2008 by dialing +1-888-286-8010 in the U.S. and entering conference ID # 63192398. The international replay number is +1-617-801-6888 with the same ID number.

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.

SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Robbins & Myers Reports Additional Gain and Increases Earnings Guidance
2. Robbins & Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call
3. Robbins & Myers to Present at Gabelli Conference
4. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
5. Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
6. Robbins Bros. Gives Water at AIDS Walk L.A.
7. Robbins & Myers Announces Regular Quarterly Cash Dividend
8. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
9. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
10. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
11. Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
Post Your Comments:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Pixel Film ... customizable media panels to choose from, the possibilities are endless. Users have full control ... With the ProPanel: Pulse masking effects, users are sure to get heads to turn. ...
(Date:11/27/2015)... Denver, CO (PRWEB) , ... November 27, 2015 , ... ... U.S. cities are not changing the way that they are handling security in light ... increasing police and security presence in an attempt to stop an attack from reaching ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... were," said an inventor from Hillside, N.J. "Many people catch diseases simply from ... that individuals will always be protected from germs." , He developed the patent-pending ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... MINNEAPOLIS, Minn. (PRWEB) , ... November 27, 2015 ... ... you start failing. Secura Consultants has prided itself for not only fulfilling the ... best income protection solutions at an affordable price and providing top-tier customer service. ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Une nouvelle approche consistant ... contre le cancer avancé.    --> ... au traitement photodynamique au Bremachlorin contre le cancer ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    Clinical Cancer Research . ...
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
Breaking Medicine Technology: